Orexigen Therapeutics, Inc.
OREX
OREX was delisted on the 3rd of April, 2018.
123 hedge funds and large institutions have $442M invested in Orexigen Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
59% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $6.53M
Top Buyers
Top Sellers
OREX Hedge Fund Activity: Q2 2013 in Review
123 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Orexigen Therapeutics, Inc. (OREX) for Q2 2013, worth a combined $442M.
Buyers outnumbered sellers: 123 funds opened new OREX positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.
- 123 institutional investors held Orexigen Therapeutics, Inc. (OREX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $442M of Orexigen Therapeutics, Inc. stock for Q2 2013.
- 123 funds opened new Orexigen Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +123 holders.
Based on aggregated 13F filings for Q2 2013.